SCHEMBL5753871

SCHEMBL5753871

NC(=O)c1cccn1-c1cccs1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.36
MAP3K14 Q99558 1/20 0.36
KDM4E B2RXH2 2/20 0.35
CES2 O00748 1/20 0.34
CES1 P23141 1/20 0.34
MAPT P10636 3/20 0.34
POLB P06746 3/20 0.34
ALDH1A1 P00352 3/20 0.34
TSHR P16473 2/20 0.34
GAA P10253 1/20 0.34
HPGD P15428 1/20 0.34
HSD17B10 Q99714 1/20 0.34
GPX4 P36969 1/20 0.33
APEX1 P27695 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
PIK3CD O00329 1/20 0.33
PIK3CA P42336 1/20 0.33
PIK3CB P42338 1/20 0.33
PIK3CG P48736 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28226342 0.72 LMNA (0.51) LMNAKDM4EMAPTALDH1A1GAA
SCHEMBL29629574 0.71 PIM1 (0.41) LMNAKDM4ECES2CES1MAPT
SCHEMBL13506760 0.71 ATM (0.46) LMNAMAP3K14KDM4EMAPTPOLB
SCHEMBL28201270 0.68 FGFR1 (0.36) KDM4EALDH1A1GAAALOX5MEN1
SCHEMBL28057093 0.68 RECQL (0.43) LMNAMAP3K14KDM4EPOLBALDH1A1
SCHEMBL9471238 0.67 TSHR (0.46) LMNAKDM4EMAPTPOLBALDH1A1
SCHEMBL20376354 0.67 PTGS2 (0.44) LMNAMAP3K14KDM4EGPX4
SCHEMBL11738105 0.67 ERCC1 (0.38) LMNAMAPTALDH1A1GAAHPGD
SCHEMBL4653135 0.66 ALDH1A1 (0.36) KDM4EMAPTPOLBALDH1A1GAA
SCHEMBL27944252 0.66 POLB (0.47) LMNAMAP3K14MAPTPOLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1670804-A2 HETEROBICYCLIC COMPOUNDS AS PHARMACEUTICALLY ACTIVE AGENTS GPC Biotech AG (DE) 2006-06-21 EP disclosed
WO-2005023818-A2 HETEROBICYCLIC COMPOUNDS AS PHARMACEUTICALLY ACTIVE AGENTS GPC BIOTECH AG (DE) 2005-03-17 WO disclosed